does semaglutide affect the kidneys in Diabetic Kidney Disease: Integrating Clinical Evidence with Mechanistic Insights Semaglutide use tied to lower

Multiple sclerosis GLP-1 receptor agonists show neuroprotective properties that extend to autoimmune conditions of the central nervous system

In rodent models, Sema has been shown to activate GLP-1 receptors in the hypothalamus, indirectly affecting TSH (thyroid-stimulating hormone) levels and downstream thyroid hormone regulation

While the MHRA has approved these treatments for adults with a body mass index (BMI) of 30 kg/m or above, or 27 kg/m with weight-related comorbidities, it's important to note that NICE guidance (TA875) specifies narrower criteria for NHS access, particularly for semaglutide, which is typically only available through specialist weight management services

Smaller contributions from cardiovascular and endocrinology specialists may reflect patients with more complex cardiometabolic profiles